Logo image of CYM.CA

CYMAT TECHNOLOGIES LTD (CYM.CA) Stock Fundamental Analysis

Canada - TSX-V:CYM - CA23257A2083 - Common Stock

0.11 CAD
0 (0%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

0

CYM gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. CYM has a bad profitability rating. Also its financial health evaluation is rather negative. CYM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CYM had negative earnings in the past year.
CYM had a negative operating cash flow in the past year.
In the past 5 years CYM always reported negative net income.
In the past 5 years CYM reported 4 times negative operating cash flow.
CYM.CA Yearly Net Income VS EBIT VS OCF VS FCFCYM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of CYM (-146.08%) is worse than 80.12% of its industry peers.
Industry RankSector Rank
ROA -146.08%
ROE N/A
ROIC N/A
ROA(3y)-125.07%
ROA(5y)-92.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYM.CA Yearly ROA, ROE, ROICCYM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYM.CA Yearly Profit, Operating, Gross MarginsCYM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

CYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CYM has more shares outstanding
CYM has a worse debt/assets ratio than last year.
CYM.CA Yearly Shares OutstandingCYM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CYM.CA Yearly Total Debt VS Total AssetsCYM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

CYM has an Altman-Z score of -56.62. This is a bad value and indicates that CYM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CYM (-56.62) is worse than 81.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -56.62
ROIC/WACCN/A
WACC7.81%
CYM.CA Yearly LT Debt VS Equity VS FCFCYM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 0.15 indicates that CYM may have some problems paying its short term obligations.
CYM has a worse Current ratio (0.15) than 80.12% of its industry peers.
CYM has a Quick Ratio of 0.15. This is a bad value and indicates that CYM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.08, CYM is doing worse than 83.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.08
CYM.CA Yearly Current Assets VS Current LiabilitesCYM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CYM have decreased by -1.75% in the last year.
CYM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.74%.
CYM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.07% yearly.
EPS 1Y (TTM)-1.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.54%
Revenue 1Y (TTM)-25.74%
Revenue growth 3Y5.91%
Revenue growth 5Y17.07%
Sales Q2Q%-90.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYM.CA Yearly Revenue VS EstimatesCYM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYM.CA Price Earnings VS Forward Price EarningsCYM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYM.CA Per share dataCYM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYMAT TECHNOLOGIES LTD

TSX-V:CYM (10/31/2025, 7:00:00 PM)

0.11

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-29 2025-09-29
Earnings (Next)12-29 2025-12-29
Inst Owners0.06%
Inst Owner ChangeN/A
Ins Owners6.84%
Ins Owner ChangeN/A
Market Cap7.23M
Revenue(TTM)1.91M
Net Income(TTM)-4017000
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.78
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.03
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -146.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-125.07%
ROA(5y)-92.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.08
Altman-Z -56.62
F-Score1
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)72.01%
Cap/Depr(5y)71.09%
Cap/Sales(3y)12.2%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.74%
Revenue growth 3Y5.91%
Revenue growth 5Y17.07%
Sales Q2Q%-90.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.01%
OCF growth 3YN/A
OCF growth 5YN/A

CYMAT TECHNOLOGIES LTD / CYM.CA FAQ

What is the ChartMill fundamental rating of CYMAT TECHNOLOGIES LTD (CYM.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to CYM.CA.


What is the valuation status for CYM stock?

ChartMill assigns a valuation rating of 0 / 10 to CYMAT TECHNOLOGIES LTD (CYM.CA). This can be considered as Overvalued.


How profitable is CYMAT TECHNOLOGIES LTD (CYM.CA) stock?

CYMAT TECHNOLOGIES LTD (CYM.CA) has a profitability rating of 0 / 10.


How financially healthy is CYMAT TECHNOLOGIES LTD?

The financial health rating of CYMAT TECHNOLOGIES LTD (CYM.CA) is 0 / 10.